Case Stories

The importance of molecular testing to improve cancer patient outcomes - Dr. Allan Njau

February 17, 2020
Dr. Allan Njau, Anatomical Pathologist at the Aga Khan University Hospital, Kenya, discusses the importance of molecular testing to improve cancer patient outcomes.

Cancer incidence rates in Kenya are high and accompanied by elevated morbidity and mortality. Dr. Allan Njao discusses how molecular NGS testing paired with a comprehensive bioinformatics analysis and reporting pipeline, can help improve cancer patient outcomes.

Interested in learning more?

Click here

Related videos

Case Stories

The importance of a good bioinformatics pipeline for determining TMB score

65 views February 17, 2020

Tumor mutational burden is an important biomarker for immuno-oncology. Dr...

Case Stories

Dr. Sehime Temel of the Department of Medical Genetics at Uludag University discusses QDI

46 views February 17, 2020

Trying to find the appropriate genetic variant without bioinformatics is as...

Case Stories

#AACR19 Interview with Deep Pandya

43 views February 17, 2020

Deep Pandya, Bioinformatician at the Western Connecticut Health Network,...

Case Stories

Bjarni Vilhjalmsson on data to sample to insight workflows helping cancer researchers

42 views February 17, 2020

At ASHG, Bjarni Vilhjalmsson presents data on sample to insight workflows...